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In 1999, Wisconsin initiated an educational campaign
for primary care clinicians and the public to promote judi-
cious antimicrobial drug use. We evaluated its impact on
clinician knowledge and beliefs; Minnesota served as a
control state. Results of pre- (1999) and post- (2002) cam-
paign questionnaires indicated that Wisconsin clinicians
perceived a significant decline in the proportion of patients
requesting antimicrobial drugs (50% in 1999 to 30% in
2002; p<0.001) and in antimicrobial drug requests from par-
ents for children (25% in 1999 to 20% in 2002; p = 0.004).
Wisconsin clinicians were less influenced by nonpredictive
clinical findings (purulent nasal discharge [p = 0.044], pro-
ductive cough [p = 0.010]) in terms of antimicrobial drug
prescribing. In 2002, clinicians from both states were less
likely to recommend antimicrobial agent treatment for the
adult case scenarios of viral respiratory illness. For the
comparable pediatric case scenarios, only Wisconsin clini-
cians improved significantly from 1999 to 2002. Although
clinicians in both states improved on several survey
responses, greater overall improvement occurred in
Wisconsin.
I
n the United States, a substantial proportion of antimicro-
bial agents are prescribed for acute respiratory infections,
including colds, upper respiratory infections (URIs), acute
bronchitis, pharyngitis, sinusitis, and otitis media (1–9).
Many of these illnesses are viral, and antimicrobial agents
offer no benefit. However, widespread and inappropriate
use of antimicrobial agents for viral illnesses has con-
tributed to the emergence of infections caused by antimi-
crobial drug-resistant organisms such as Streptococcus
pneumoniae (10–12). The proportion of invasive infections
caused by penicillin-nonsusceptible S.  pneumoniae
increased nationally from 1% in 1992 to 27% in 2000 (10).
Multidrug resistance has also occurred with increasing fre-
quency: the proportion of S. pneumoniae isolates nonsus-
ceptible to >3 classes of antimicrobial drugs increased from
7% in 1995 to 19% in 2000 (10). Multiple studies have
shown a strong and consistent association between recent
antimicrobial drug use and infection with a drug-resistant
strain of pneumococcus (13–18). More recently, rapidly
increasing rates of fluoroquinolone use have also been
implicated in the emergence of fluoroquinolone-resistant
pneumococcal infections (19–22). The increase in antimi-
crobial drug–resistant infections has economic as well as
clinical implications; the annual cost of unnecessary
antimicrobial drug prescribing for acute respiratory infec-
tions has been estimated to be ≈$726 million (5).
Throughout the previous decade, multiple interventions
aimed at patients and clinicians have been implemented to
promote appropriate antimicrobial drug use and prevent
the development of antimicrobial resistance. In Wisconsin,
a multifaceted educational campaign focusing on clini-
cians and the public was launched in late 1999 by the
Wisconsin Antibiotic Resistance Network (WARN).
Clinician education included presentations at professional
meetings, conferences, and grand rounds; continuing med-
ical education satellite conferences; distribution of slide
presentations on CD-ROM; and multiple mailings of edu-
cational materials to all primary care clinicians. The pub-
lic education component consisted of multilingual
brochures and posters, tear-off sheets, coloring sheets,
stickers, magnets, and handouts. These items were distrib-
uted statewide to clinics, managed care organizations,
pharmacies, childcare facilities, and community groups.
Mass media activities included radio advertisements
statewide and paid television advertisements in selected
Clinician Knowledge and 
Beliefs after Statewide Program 
to Promote Appropriate
Antimicrobial Drug Use
Karen M. Kiang,*† Burney A. Kieke,‡ Kathryn Como-Sabetti,* Ruth Lynfield,* Richard E. Besser,† 
and Edward A. Belongia‡
RESEARCH
904 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 6, June 2005
*Minnesota Department of Health, Minneapolis, Minnesota, USA;
†Centers for Disease Control and Prevention, Atlanta, Georgia,
USA; and ‡Marshfield Clinic Research Foundation, Marshfield,
Wisconsin, USAmarkets. A more detailed account of WARN campaign
activities is provided in the accompanying article (23). The
purpose of this study was to assess the impact of the
WARN campaign on the knowledge, beliefs, and decision-
making of Wisconsin primary care clinicians regarding
appropriate antimicrobial drug use for upper respiratory
infections. 
Methods
Design and Study Population
The study consisted of serial cross-sectional surveys in
2 states with pre- and postintervention measurements.
Minnesota served as a control state to distinguish interven-
tion-related changes from the regional secular trend.
Minnesota was selected for geographic proximity and sim-
ilarity in terms of population size and racial/ethnic distri-
bution. Before 2002, educational activities on appropriate
antimicrobial drug use were limited in Minnesota.
Approval for this study was obtained from the institution-
al review board of CDC. 
Eligible participants for the survey included physicians,
nurse practitioners, and physician assistants. Practice spe-
cialties for physicians and physician assistants included
family practice, pediatrics, internal medicine, emergency
medicine, and general practice. Specialties for nurse prac-
titioners included family practice and pediatrics. In 1999
and 2002, independent random samples were selected
from Wisconsin and Minnesota licensing databases. The
1999 sampling frame was 7,113 in Wisconsin and 6,335 in
Minnesota; the 2002 sampling frame was 6,218 in
Wisconsin and 5,800 in Minnesota. The survey sample
included 400 Wisconsin and 400 Minnesota clinicians in
1999, and 600 Wisconsin and 400 Minnesota clinicians in
2002. The baseline sample size was selected to provide
>80% power to detect a 15% increase in the proportion of
clinicians giving the correct or desired response to a
specific survey question (α = 0.05). Wisconsin clinicians
were oversampled in 2002 to facilitate a within-state
analysis of the impact of a television advertising campaign
(not reported here). The probability of the same clinician
being sampled in both 1999 and 2002 was low, and the
samples were considered independent in the analyses.
Questionnaire
The preintervention questionnaire was mailed to
Wisconsin clinicians in April 1999 and to Minnesota clini-
cians in November 1999. During March–May 2002, the
postintervention questionnaire was mailed to clinicians in
both states. The questionnaires contained a cover letter
explaining the purpose of the survey; 2 follow-up
reminders were sent to maximize compliance. The prein-
tervention and postintervention questionnaires were iden-
tical in their measures of knowledge, beliefs, and decision
making and differed only in the addition of questions to the
preintervention questionnaire regarding clinician opinion
for effective campaign materials (for planning purposes)
and the addition of questions to Wisconsin’s postinterven-
tion questionnaire about the television advertisements. 
After determining practice setting and basic demo-
graphics, clinicians caring for adults were asked to esti-
mate the proportion of adult patients who requested
antimicrobial agents for cough, cold, or flulike symptoms.
Likewise, those caring for children were asked to estimate
the proportion of parents who requested antimicrobial
agents for their child. The survey questionnaire (Figure 1)
then asked a series of questions to assess 1) the influence
of 2 nonpredictive clinical factors (i.e., clinical symptoms
or signs characteristic of both viral and bacterial infec-
tions, which therefore did not necessarily warrant antimi-
crobial drug therapy) and 1 social factor on the decision to
prescribe antimicrobial drugs; 2) the likelihood of antimi-
crobial agent prescribing in adult and pediatric clinical
case scenarios for URIs and bronchitis; and 3) perceptions
and beliefs regarding patient expectations and peer-estab-
lished norms. In addition, questions regarding exposure to
and perceived impact of the WARN campaign were asked
on the postintervention questionnaire (Wisconsin clini-
cians only). For most questions, the responses were based
on a 5-point Likert-scale (e.g., “strongly disagree to
strongly agree”). The Likert responses were dichotomized
into desired and undesired responses (Figure 1); responses
were classified as “desired” if they were consistent with
national pediatric and adult clinical practice guidelines or
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Figure 1. Representation of survey items assessed in 1999 and
2002 among Wisconsin and Minnesota clinicians.the educational goals of the WARN campaign. The influ-
ence of social factors, patient expectations, and peer-
established norms on clinical decision-making was
considered “undesired” since each was an inappropriate
reason for antimicrobial drug prescribing.  
Statistical Analysis
For the clinician-reported estimates of the percentage of
patients or parents who requested an antimicrobial drug,
we compared the distribution of responses for each year
and state. We used the 1-sided Jonckheere-Terpstra test, a
generalization of the nonparametric Mann-Whitney U test,
to compare within-state distributions for 1999 and 2002.
The null hypothesis was that the distributions did not dif-
fer between these 2 periods.
For each Likert-scale question, we calculated a ratio
based on the proportion of clinicians with a desired
response in 2002 (numerator) divided by the proportion
with a desired response in 1999 (denominator). A ratio
>1.0 indicated improvement in 2002 versus 1999. After
calculating this ratio for each state, we compared the ratios
between Wisconsin and Minnesota. All ratios were adjust-
ed for clinician sex, years in practice, practice setting, and
clinician type. All adjusted ratios and corresponding statis-
tical test results were obtained directly from multivariable
models similar to logistic regression models but with a log
(rather than logit) link function (24). Such models permit
comparison of proportions rather than odds. The models
included terms for state, year, their interaction, and the
control variables (clinician sex, years in practice, practice
setting, and clinician type). Examining appropriate combi-
nations of the estimated parameters from these models per-
mitted within-year comparisons of Wisconsin versus
Minnesota (e.g., baseline comparisons), within-state com-
parisons of 2002 versus 1999, and between-state compar-
isons of within-state ratios (i.e., comparisons of the
2002/1999 ratios for Wisconsin to those in Minnesota for
estimating the effect in Wisconsin beyond that observed in
Minnesota).
Ten percent of questionnaire responses were entered in
duplicate for quality assurance. Statistical analyses were
performed by using SAS version 8.2 (SAS Institute Inc.,
Cary, NC, USA) and EpiInfo 6 (CDC, Atlanta, GA, USA). 
Results
The survey response rates ranged from 65% to 71%.
Most respondents were physicians (Table 1). The most
common practice specialty was family practice. The sex
distribution and years in practice in each group did not dif-
fer by state or year of survey. 
Baseline Survey
Baseline responses were compared for Wisconsin and
Minnesota in 1999, before initiation of the WARN cam-
paign in Wisconsin. Clinicians in Wisconsin and
Minnesota perceived similar proportions of their adult
patients requesting antimicrobial agents (p = 0.217)
(Figure 2). The median percentage of patients perceived to
request antimicrobial agents was 50% in Wisconsin and
40% in Minnesota; this difference was not significant. The
perceived demand by parents for antimicrobial agents to
treat their child’s respiratory illness was also similar
between the 2 states (p = 0.473) (Figure 3); the median
reported percentage of parents requesting antimicrobial
agents was 25% in both states.
Clinicians in Wisconsin and Minnesota gave similar
baseline responses regarding the influence of a social fac-
tor (e.g., patient states antimicrobial agents given for sim-
ilar symptoms in the past) and a nonpredictive clinical
factor (e.g., purulent nasal discharge) (Table 2, baseline p
values not presented). However, Minnesota clinicians were
significantly more likely to report that productive cough
with purulent sputum would not influence their decision to
prescribe an antimicrobial agent (Wisconsin 14%,
Minnesota 20%, p = 0.027). For the bronchitis and viral
URI case scenarios, the overall proportion of clinicians
who would withhold antimicrobial agents was similar in
each state. The proportion who would withhold antimicro-
bial agents was greater for the pediatric case scenarios than
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belief questions regarding patient expectations and clini-
cian peer norms were similar between the states during the
baseline period (Table 4).
We also compared baseline responses between states
for clinicians in practice <10 years and those in practice
>10 years. For those in practice <10 years, a higher propor-
tion of Minnesota clinicians indicated that their decision to
use antimicrobial agents was not influenced by purulent
nasal discharge (Wisconsin 36%, Minnesota 51%, p =
0.024) or cough with productive sputum (Wisconsin 12%,
Minnesota 25%, p = 0.005). Responses to the influence of
the social factor and responses to the adult and pediatric
case scenarios were similar between the states. For clini-
cians in practice >10 years, responses were similar
between the 2 states regarding the influence of nonpredic-
tive clinical factors and the social factor. Compared to
Wisconsin clinicians practicing >10 years, a higher propor-
tion of Minnesota clinicians in long-term practice indicat-
ed they would withhold antimicrobial agents in the
pediatric case scenarios (p = 0.048) and the adult case sce-
narios (p = 0.118).
Within Wisconsin, some baseline responses differed
according to length of time in practice.  A significantly
higher proportion of clinicians practicing <10 years gave
the desired responses for the pediatric (p = 0.027) and
adult (p = 0.002) case scenarios. They were also more like-
ly to give the desired response regarding the influence of a
social factor (i.e., patient states antimicrobial agents were
given for similar symptoms in the past) (p = 0.043).
Wisconsin clinicians in practice <10 years and those in
practice >10 years gave similar responses regarding the
influence of the nonpredictive clinical factors (i.e., puru-
lent nasal discharge and productive cough).
When specialties were compared, a higher proportion
of pediatric clinicians gave desired responses than clini-
cians in other specialties on most outcome measure in both
Wisconsin and Minnesota. Baseline comparisons between
physicians and nonphysicians did not show a consistent
tendency for 1 group to perform better than the other. 
Follow-up Survey
In 2002, Wisconsin clinicians perceived less demand for
antimicrobial agents among adult patients compared with
1999 (p<0.001) (Figure 2). Based on clinician estimates,
the median percentage of patients who requested an antimi-
crobial agent for cough, cold, or flu symptoms decreased
from 50% in 1999 to 30% in 2002. Minnesota clinicians
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Figure 2. Proportion of clinicians reporting various estimates of the
percentage of their adult patients who requested an antimicrobial
agent for cough, cold, or flulike symptoms in 1999 and 2002.also perceived a decrease in the percentage of patients who
requested antimicrobial agents, but the difference was not
significant (p = 0.152) (Figure 2); the median percentage of
Minnesota patients requesting antimicrobial agents
decreased from 40% in 1999 to 30% in 2002.
In both states, a decline was noted in the perceived
parental demand for antimicrobial agents to treat pediatric
respiratory illness (Figure 3). The temporal change was
significant in Wisconsin (p = 0.004) and approaching sig-
nificance in Minnesota (p = 0.064). The median reported
percentage of parents who requested an antimicrobial
agent decreased from 25% in 1999 to 20% in 2002 in both
states, but the distribution around the medians differed sig-
nificantly between the states. 
In Wisconsin, significant improvement occurred in the
responses to the 2 questions about nonpredictive clinical
factors and the social factor that may increase the likeli-
hood of prescribing antimicrobial agents (i.e., purulent
nasal discharge, productive cough, and patient or parent
statement that antimicrobial agents were prescribed for
similar symptoms in the past) (Table 2). Wisconsin clini-
cians were significantly more likely to report that each fac-
tor did not influence antimicrobial agent prescribing
practices in 2002 compared with 1999. In Minnesota, a
significant improvement occurred in responses regarding
the influence of purulent nasal discharge, but no signifi-
cant change occurred for the other 2 factors. Overall,
Wisconsin clinicians demonstrated significant improve-
ment regarding the influence of purulent nasal discharge (p
= 0.044) and productive cough (p = 0.010) after account-
ing for temporal changes in Minnesota.
Both Minnesota and Wisconsin clinicians improved in
their responses to the adult case scenarios for URI and
bronchitis (Table 3). The magnitude of improvement was
greater for Wisconsin clinicians, but the improvement in
Wisconsin was not significant after accounting for the sec-
ular trend in Minnesota. In the pediatric case scenarios,
Wisconsin clinicians improved from 1999 to 2002 (p =
0.058), while the responses of Minnesota clinicians were
essentially unchanged (p = 0.807). 
Wisconsin clinicians demonstrated a modest improve-
ment from 1999 to 2002 in response to questions concern-
ing perceived clinician peer norms and patient
expectations, but the changes in Wisconsin were not sig-
nificant after accounting for temporal changes in
Minnesota (p = 0.103 and 0.519, respectively, Table 4). 
Subgroup Analysis
Responses were analyzed separately for clinicians who
had practiced >10 years (1999, n = 198; 2002, n = 243) and
those in practice <10 years (1999, n = 187; 2002, n = 239).
In Wisconsin, clinicians who were in practice for the
longer period demonstrated significant improvements
regarding the likelihood of prescribing antimicrobial
agents for purulent nasal discharge (2002 to 1999 ratio =
1.61, p = 0.005) and productive cough (2002 to 1999 ratio
= 2.35, p = 0.001). They also improved in their responses
to the influence of patient/parent statement that antimicro-
bial agents were prescribed for similar symptoms in the
past (2002 to 1999 ratio = 1.36, p = 0.012). Wisconsin cli-
nicians practicing >10 years also demonstrated significant
improvements in the adult case scenarios (2002 to 1999
ratio = 2.00, p<0.001) and the pediatric case scenarios
(2002 to 1999 ratio = 1.43, p = 0.002)] and in the questions
concerning patient expectations and peer norms. The 2002
to 1999 ratio was 1.40 (p = 0.031) for patient expectations
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responses to the pediatric case scenarios improved signifi-
cantly among physicians in practice >10 years (p = 0.027)
after accounting for the secular trend in Minnesota. 
Wisconsin clinicians in practice <10 years improved in
fewer areas. They improved significantly in responses
regarding the influence of purulent nasal discharge
(p<0.001) and productive cough (p<0.001) on antimicro-
bial agent prescribing practices, and both factors remained
significant after accounting for the secular trend. No sig-
nificant change occurred in the other responses. A direct
comparison between Wisconsin clinicians practicing <10
years to those practicing >10 years demonstrated no signif-
icant difference with regard to improvement in knowledge
or the response to the clinical scenarios. 
Familiarity with WARN and WARN Materials
Ninety percent of primary care clinicians in Wisconsin
had heard of WARN. Of those, 70% had used WARN
patient education materials. Of those using the materials,
41% reported that they were “very useful,” and 59% said
that they were “somewhat useful.”
Discussion
The results of this study demonstrated significant
improvement among primary care clinicians in multiple
outcome measures after a multifaceted educational cam-
paign to promote appropriate antimicrobial drug use in
Wisconsin was implemented. From 1999 to 2002, clini-
cians perceived less patient or parent demand for antimicro-
bial agents and were less likely to report that antimicrobial
agent prescribing was influenced by social and nonpredic-
tive clinical factors. Clinicians demonstrated improved
decision-making in adult and pediatric case scenarios for
URIs and bronchitis and perceived less pressure from
patients and peers to prescribe. Minnesota clinicians also
demonstrated improvement in some of these factors, but the
magnitude of improvement was consistently greater among
Wisconsin clinicians, and the improvements in several of
these factors in Wisconsin remained significant even after
the secular trend in Minnesota was accounted for. 
The greater improvements in responses from Wisconsin
clinicians over time compared with Minnesota clinicians
suggest that the WARN program had a positive effect on
clinician knowledge and beliefs. This effect is supported
by the observations that among Wisconsin clinicians, a
high level of recognition and acceptance of WARN was
achieved, and that from 2000 through 2002, the use of
WARN educational materials was widespread. 
The WARN campaign was initiated in 1999 as a large-
scale demonstration project designed to promote appropri-
ate antimicrobial agent use for outpatient respiratory
illness. It was the largest of its kind in the United States
and the first to evaluate whether prescribing practices
could be improved for an entire state. At the time the proj-
ect was initiated, clinicians perceived a high demand for
antimicrobial agents and displayed prominent gaps in
knowledge regarding outpatient antimicrobial agent use
for URIs and bronchitis (4,25–28). At the same time,
knowledge of appropriate antimicrobial agent use was lim-
ited among much of the general public (27–30).
The results of this study are consistent with those of
other studies demonstrating the impact of multifaceted
educational efforts that specifically focused on physicians,
patients, or the general public. Campaigns that focused
on parents, using videotaped presentations in pediatric
waiting rooms, showed modest to significant improvement
in parental knowledge and attitudes about appropriate
antimicrobial agent use (31,32), but in-service reviews of
judicious antimicrobial agent use guidelines for clinicians
had no effect on antimicrobial agent prescribing rates (32).
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Figure 3. Proportion of clinicians reporting various estimates of the
percentage of parents of their pediatric patients who requested
antimicrobial drugs for their child's cough, cold, or flulike symp-
toms in 1999 and 2002.Intensive education of both the clinicians and the commu-
nity has led to significant decreases in antimicrobial agent
prescription rates, as shown by studies in Knox County,
Tennessee (33), eastern Massachusetts, northwest
Washington state (34), the Denver metropolitan area (35),
northern Wisconsin communities (36), and rural Alaskan
villages (37). Only the Tennessee study addressed a large
general population, whereas the other studies focused on
rural communities or managed care populations.
In subgroup analysis, we found the greatest improve-
ments among Wisconsin clinicians who had been in prac-
tice for >10 years. Although these improvements coincided
with the secular trend observed in Minnesota, they demon-
strate that this group of physicians should be targeted for
further education. One potential explanation for why clini-
cians who were trained more recently showed fewer
improvements is that they might already have a greater
awareness of issues regarding increasing antimicrobial
drug resistance and were trained more rigorously in the
principles of judicious antimicrobial drug use. This
hypothesis was supported by the baseline assessment,
which showed that clinicians practicing <10 years per-
formed better on the clinical case scenarios. These results
parallel other findings that clinicians who are temporally
further away from medical training programs prescribe
antimicrobial drugs more frequently (38), although this
finding has not been consistently demonstrated (4,26).
This study did not include objective measures of
antimicrobial drug prescribing. Prior studies have shown
that changes in knowledge and attitudes do not necessarily
translate into changed in clinical practice (4,25). The med-
ical culture surrounding antimicrobial drug prescribing in
the United States is influenced by multiple external factors
(e.g., peer practices, pharmaceutical detailing, geographic
region, and managed care restrictions), and these may
influence practice more than knowledge of current guide-
lines. The accompanying study by Belongia et al. address-
es the impact of WARN on antimicrobial drug prescribing
rates in Wisconsin relative to those of Minnesota (23).
A limitation of this study was the lack of statistical
power to detect modest improvements after accounting for
the secular trend in Minnesota. The magnitude of improve-
ment in Wisconsin consistently exceeded that in
Minnesota, but the difference was often deemed statistical-
ly insignificant. A larger sample size may have provided
additional power to distinguish between these smaller dif-
ferences. In addition, a higher proportion of Minnesota cli-
nicians gave the correct or desired response to several of
the baseline survey items compared with Wisconsin clini-
cians, although many of these differences were not statis-
tically significant. Minnesota clinicians may have had less
room to improve and might have already been more
familiar with recommendations regarding judicious
antimicrobial drugs use; therefore, Minnesota might not
have been wholly optimal as a control state. Additionally,
Minnesota clinicians and public along the Wisconsin-
Minnesota border may have been exposed to WARN mate-
rials and advertisements. An added limitation is that this
study included only 2 states. If substantially more
resources had been available, a controlled, multistate inter-
vention study would have provided more robust and gen-
eralizable results. Alarger study may no longer be feasible,
given the success of current campaigns in promoting
awareness on a national level. The efficacy of large multi-
faceted interventional campaigns will be difficult to evalu-
ate because unexposed populations no longer exist.
In conclusion, this study suggests that the WARN cam-
paign had at least a modest positive effect on the knowl-
edge and decision-making of primary care clinicians in
Wisconsin. Clinicians in practice >10 years demonstrated
the greatest improvements and may benefit most from edu-
cational interventions. Further research should include the
development and evaluation of interventions to improve
antimicrobial agent selection (narrow-spectrum versus
broad-spectrum) and an assessment of new clinical strate-
gies to optimize antimicrobial agent usage (e.g., a 72-hour
waiting period for selected patients with mild acute otitis
media) (39,40). The documented success of these smaller
campaigns in changing the medical culture surrounding
antimicrobial drug prescribing has prompted its expansion
to the national level. Anational public education campaign
was launched by CDC in September 2003 to further gener-
ate provider and public awareness of these issues and to
curb the inappropriate use of antimicrobial drugs.
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